首页> 外文期刊>World Poultry >Innovative vaccines reviewed at AVMA congress
【24h】

Innovative vaccines reviewed at AVMA congress

机译:在AVMA大会上审查了创新疫苗

获取原文
获取原文并翻译 | 示例
           

摘要

Basic studies on molecular biology are now being translated into potential vaccines for breeders, table egg producers and broiler and turkey integrators. A report on recent findings.Reports on innovative poultry vaccines were presented at the 2004 Congress of the American Veterinary Medical Association held in Philadelphia in July. Dr Eid Haddad of Embrex, Inc., reported on the protection against New Castle Disease provided by Newplex~R VNF vaccine following in-ovo administration to broiler embryos derived from flocks with maternal antibody. Adequate protection was demonstrated at 7 days after hatch and immunity persisted through 84 days as denoted by challenge with the highly virulent Texas GB strain.c
机译:分子生物学的基础研究现已被转化为育种者,食用鸡蛋生产者以及肉鸡和火鸡整合者的潜在疫苗。最近发现的报告.7月在费城举行的2004年美国兽医医学协会大会上提交了有关创新性家禽疫苗的报告。 Embrex,Inc.的Eid Haddad博士报告了Newplex_R VNF疫苗对卵母体来源的肉鸡胚胎进行卵内给药后对新城疫的保护作用。孵化后第7天证明了足够的保护作用,并且免疫力持续了84天,这表现为用高毒力的德州GB菌株激发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号